Modified Nucleosides
6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine
Quick view. 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine is listed for research-use inquiry under Modified Nucleosides. Its identity is controlled by the retained exact structure and product-form evidence because no public CAS Registry Number is assigned. A public CAS number is not assigned for this exact form. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
![Chemical structure of 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine](/structures/7c741987ca9400dd.svg)
Product profile
6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine is classified as modified nucleosides (Formula C27H29N7O6; molecular weight 547.60 g/mol).
6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine is supplied for research use within the Modified Nucleosides product family.
For 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Physicochemical data
| CAS status | No public CAS assigned |
|---|---|
| Identity control | Reviewed exact name, structure, and product form |
| InChIKey | UQLYRXRJRDMOBL-CMDJAWNXSA-N |
| InChI | InChI=1S/C27H29N7O6/c35-15-22-21(36)13-23(40-22)33-16-29-24-25(33)30-27(32-11-2-4-20(32)18-3-1-10-28-14-18)31-26(24)39-12-9-17-5-7-19(8-6-17)34(37)38/h1,3,5-8,10,14,16,20-23,35-36H,2,4,9,11-13,15H2/t20?,21-,22+,23+/m0/s1 |
| SMILES | C1CC(N(C1)C2=NC3=C(C(=N2)OCCC4=CC=C(C=C4)[N+](=O)[O-])N=CN3[C@H]5C[C@@H]([C@H](O5)CO)O)C6=CN=CC=C6 |
| Canonical SMILES | C1CC(N(C1)C2=NC3=C(C(=N2)OCCC4=CC=C(C=C4)[N+](=O)[O-])N=CN3[C@H]5C[C@@H]([C@H](O5)CO)O)C6=CN=CC=C6 |
| PubChem CID | 175676338 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0610, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.